Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Keymed Biosciences secures NMPA approval for Stapokibart in chronic rhinosinusitis treatment
Keymed Biosciences Inc. (HKEX: 02162) has received a significant regulatory endorsement as the National Medical Products Administration (NMPA) of China approved its supplemental New Drug ... Read More
CStone Pharmaceuticals advances cancer research with first-in-human clinical trial application for CS2009
CStone Pharmaceuticals, an innovation-driven biopharmaceutical company listed on the Hong Kong Stock Exchange (HKEX: 2616), has taken a significant step forward in its mission to ... Read More
Sanofi strengthens cardiovascular portfolio with Aficamten rights in Greater China
Cytokinetics, Incorporated (NASDAQ: CYTK) saw its shares climb by 4.8% after announcing a landmark agreement with Sanofi (NASDAQ: SNY). The deal grants Sanofi exclusive rights ... Read More
Novo Nordisk’s CagriSema demonstrates superior weight loss results in REDEFINE 1 trial
Novo Nordisk A/S has unveiled significant findings from its REDEFINE 1 trial, marking a major advancement in the treatment of obesity and overweight conditions. Conducted ... Read More
Vanda Pharmaceuticals’ VGT-1849A gets orphan drug designation for polycythemia vera treatment
Vanda Pharmaceuticals Inc. has achieved a critical regulatory milestone with the U.S. Food and Drug Administration (FDA) granting orphan drug designation to its investigational therapy ... Read More
Omeros stock skyrockets as narsoplimab improves survival in pivotal TA-TMA trial
Omeros Corporation, a Seattle-based biopharmaceutical company, is making waves after releasing results from its pivotal clinical trial for narsoplimab, a monoclonal antibody designed to treat ... Read More
Merck invests $50m in Personalis to bolster Moderna collaboration on individualized cancer therapies
Personalis, Inc., a leader in precision oncology solutions, has secured a significant investment from Merck and extended its partnership with Moderna. These strategic agreements aim ... Read More
Ocugen reports promising interim results for OCU410 clinical trial in geographic atrophy
Ocugen, Inc. has taken a significant step forward in the fight against geographic atrophy (GA) secondary to dry age-related macular degeneration (dAMD), a leading cause ... Read More
Bio-Path Holdings unveils preclinical success for BP1001-A in treating obesity and Type 2 diabetes
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology innovator known for leveraging its DNAbilize liposomal delivery platform, has announced promising preclinical study results for BP1001-A, a ... Read More
Cognition Therapeutics reports promising Phase 2 results for CT1812 in dementia with Lewy bodies
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage pharmaceutical company focused on neurodegenerative disorder treatment, has reported highly encouraging Phase 2 trial results for CT1812, a ... Read More